WASHINGTON — Just over nine months after President Trump signed an executive order mandating that each new regulation must be accompanied by suggestions for two regulations to eliminate, the head of one regulatory agency told the public that his agency can accomplish this in what might seem like a paradoxical manner — by creating more regulations.

“We actually deregulate by regulating,” Food and Drug Administration Commissioner Scott Gottlieb said at a luncheon. He noted that this was not “some magical construct we’ve adopted … over the last six months” but rather that it was the agency’s normal way of doing business.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy